ID: ALA5277709

Max Phase: Preclinical

Molecular Formula: C21H21IN2O

Molecular Weight: 444.32

Associated Items:

Representations

Canonical SMILES:  CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2[123I])n1

Standard InChI:  InChI=1S/C21H21IN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3/i22-4

Standard InChI Key:  PYUYMBOKENEYDV-NHTLRXQVSA-N

Associated Targets(Human)

Translocator protein 484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 444.32Molecular Weight (Monoisotopic): 444.0699AlogP: 5.38#Rotatable Bonds: 4
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.97CX LogP: 5.69CX LogD: 5.69
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.51Np Likeness Score: -0.93

References

1. Giordani A, Menziani MC, Moresco RM, Matarrese M, Paolino M, Saletti M, Giuliani G, Anzini M, Cappelli A..  (2021)  Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria.,  64  (14.0): [PMID:34254805] [10.1021/acs.jmedchem.1c00379]

Source